Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lentigen Technology
Gaithersburg, Maryland, United Stateslentigen.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Lentigen Technology was a leading provider of GMP-compliant lentiviral vectors used in clinical-stage gene and cell therapies, supporting multiple partners’ programs including CAR-T cell immunotherapies. The company’s technology enabled efficient gene delivery for both research and commercial applications. It did not develop its own therapeutics but played a critical role in enabling advanced therapies to reach the clinic.
- Therapeutic areas
- Rare DiseasesOncology
- Modalities
- Gene therapyCell therapyViral vector
- Industry
- Non-Drug Biotech
02
Partnerships
Oncternal TherapeuticsTxCellWave BiotechThermoFisher ScientificThe National Institutes of HealthThe University of PennsylvaniaU.S. Army
Beyond the preview
Go deeper on Lentigen Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lentigen Technology.